Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HEE6
Term | Name | Level | Count |
---|---|---|---|
GO:0000738 | obsolete DNA catabolic process, exonucleolytic | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006259 | DNA metabolic process | 4 | 1 |
GO:0006308 | DNA catabolic process | 5 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004518 | nuclease activity | 4 | 10 |
GO:0004527 | exonuclease activity | 5 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 10 |
GO:0016787 | hydrolase activity | 2 | 10 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0004529 | DNA exonuclease activity | 5 | 1 |
GO:0004536 | DNA nuclease activity | 4 | 1 |
GO:0008296 | 3'-5'-DNA exonuclease activity | 7 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 398 | 402 | PF00656 | 0.653 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.558 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.298 |
CLV_NRD_NRD_1 | 231 | 233 | PF00675 | 0.290 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.568 |
CLV_NRD_NRD_1 | 460 | 462 | PF00675 | 0.755 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.542 |
CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.576 |
CLV_PCSK_KEX2_1 | 460 | 462 | PF00082 | 0.582 |
CLV_PCSK_KEX2_1 | 477 | 479 | PF00082 | 0.758 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.535 |
CLV_PCSK_PC1ET2_1 | 477 | 479 | PF00082 | 0.768 |
CLV_PCSK_PC1ET2_1 | 76 | 78 | PF00082 | 0.535 |
CLV_PCSK_PC7_1 | 226 | 232 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.211 |
CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.441 |
CLV_PCSK_SKI1_1 | 454 | 458 | PF00082 | 0.732 |
CLV_PCSK_SKI1_1 | 461 | 465 | PF00082 | 0.681 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.453 |
DEG_MDM2_SWIB_1 | 160 | 168 | PF02201 | 0.531 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.693 |
DOC_AGCK_PIF_1 | 88 | 93 | PF00069 | 0.357 |
DOC_ANK_TNKS_1 | 135 | 142 | PF00023 | 0.557 |
DOC_CKS1_1 | 171 | 176 | PF01111 | 0.508 |
DOC_CYCLIN_yCln2_LP_2 | 84 | 90 | PF00134 | 0.372 |
DOC_MAPK_gen_1 | 10 | 17 | PF00069 | 0.636 |
DOC_MAPK_gen_1 | 230 | 236 | PF00069 | 0.531 |
DOC_MAPK_gen_1 | 3 | 9 | PF00069 | 0.578 |
DOC_MAPK_gen_1 | 76 | 84 | PF00069 | 0.525 |
DOC_MAPK_HePTP_8 | 74 | 86 | PF00069 | 0.524 |
DOC_MAPK_MEF2A_6 | 77 | 86 | PF00069 | 0.526 |
DOC_PP1_RVXF_1 | 164 | 171 | PF00149 | 0.469 |
DOC_PP2B_LxvP_1 | 84 | 87 | PF13499 | 0.383 |
DOC_PP4_FxxP_1 | 97 | 100 | PF00568 | 0.490 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 336 | 340 | PF00917 | 0.697 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.700 |
DOC_USP7_MATH_1 | 442 | 446 | PF00917 | 0.644 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.508 |
DOC_WW_Pin1_4 | 252 | 257 | PF00397 | 0.438 |
DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.414 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.543 |
DOC_WW_Pin1_4 | 383 | 388 | PF00397 | 0.645 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.613 |
LIG_14-3-3_CanoR_1 | 231 | 237 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 268 | 272 | PF00244 | 0.561 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.607 |
LIG_14-3-3_CanoR_1 | 350 | 355 | PF00244 | 0.796 |
LIG_14-3-3_CanoR_1 | 419 | 424 | PF00244 | 0.753 |
LIG_14-3-3_CanoR_1 | 482 | 488 | PF00244 | 0.537 |
LIG_14-3-3_CanoR_1 | 69 | 78 | PF00244 | 0.482 |
LIG_14-3-3_CanoR_1 | 89 | 94 | PF00244 | 0.170 |
LIG_AP2alpha_1 | 373 | 377 | PF02296 | 0.646 |
LIG_BRCT_BRCA1_1 | 214 | 218 | PF00533 | 0.531 |
LIG_BRCT_BRCA1_1 | 84 | 88 | PF00533 | 0.378 |
LIG_Clathr_ClatBox_1 | 368 | 372 | PF01394 | 0.701 |
LIG_Clathr_ClatBox_1 | 63 | 67 | PF01394 | 0.423 |
LIG_deltaCOP1_diTrp_1 | 162 | 170 | PF00928 | 0.531 |
LIG_FHA_1 | 107 | 113 | PF00498 | 0.490 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.506 |
LIG_FHA_1 | 322 | 328 | PF00498 | 0.698 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.527 |
LIG_FHA_1 | 363 | 369 | PF00498 | 0.718 |
LIG_FHA_1 | 491 | 497 | PF00498 | 0.741 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.414 |
LIG_FHA_2 | 285 | 291 | PF00498 | 0.402 |
LIG_IRF3_LxIS_1 | 248 | 255 | PF10401 | 0.411 |
LIG_LIR_Apic_2 | 94 | 100 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 123 | 133 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 162 | 171 | PF02991 | 0.508 |
LIG_LIR_Gen_1 | 270 | 279 | PF02991 | 0.533 |
LIG_LIR_Gen_1 | 370 | 377 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 5 | 13 | PF02991 | 0.618 |
LIG_LIR_Gen_1 | 81 | 91 | PF02991 | 0.370 |
LIG_LIR_Nem_3 | 123 | 129 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.503 |
LIG_LIR_Nem_3 | 242 | 246 | PF02991 | 0.559 |
LIG_LIR_Nem_3 | 270 | 274 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 370 | 376 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 5 | 9 | PF02991 | 0.557 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.370 |
LIG_PDZ_Class_2 | 494 | 499 | PF00595 | 0.710 |
LIG_Pex14_1 | 271 | 275 | PF04695 | 0.396 |
LIG_Pex14_2 | 160 | 164 | PF04695 | 0.490 |
LIG_Pex14_2 | 373 | 377 | PF04695 | 0.546 |
LIG_Pex14_2 | 93 | 97 | PF04695 | 0.490 |
LIG_SH2_CRK | 118 | 122 | PF00017 | 0.561 |
LIG_SH2_CRK | 275 | 279 | PF00017 | 0.521 |
LIG_SH2_PTP2 | 6 | 9 | PF00017 | 0.426 |
LIG_SH2_STAP1 | 80 | 84 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 308 | 311 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 6 | 9 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.361 |
LIG_SH3_3 | 114 | 120 | PF00018 | 0.430 |
LIG_SH3_3 | 168 | 174 | PF00018 | 0.561 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.576 |
LIG_SUMO_SIM_anti_2 | 182 | 190 | PF11976 | 0.591 |
LIG_SUMO_SIM_anti_2 | 197 | 202 | PF11976 | 0.490 |
LIG_SUMO_SIM_par_1 | 182 | 190 | PF11976 | 0.508 |
LIG_SUMO_SIM_par_1 | 232 | 237 | PF11976 | 0.531 |
LIG_SUMO_SIM_par_1 | 365 | 372 | PF11976 | 0.738 |
LIG_TRAF2_1 | 388 | 391 | PF00917 | 0.756 |
LIG_UBA3_1 | 186 | 194 | PF00899 | 0.490 |
LIG_WRC_WIRS_1 | 90 | 95 | PF05994 | 0.361 |
MOD_CDK_SPK_2 | 284 | 289 | PF00069 | 0.414 |
MOD_CK1_1 | 339 | 345 | PF00069 | 0.673 |
MOD_CK1_1 | 353 | 359 | PF00069 | 0.806 |
MOD_CK1_1 | 362 | 368 | PF00069 | 0.727 |
MOD_CK1_1 | 408 | 414 | PF00069 | 0.749 |
MOD_CK1_1 | 468 | 474 | PF00069 | 0.788 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.643 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.414 |
MOD_Cter_Amidation | 134 | 137 | PF01082 | 0.308 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.211 |
MOD_GlcNHglycan | 334 | 337 | PF01048 | 0.772 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.769 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.778 |
MOD_GlcNHglycan | 361 | 364 | PF01048 | 0.747 |
MOD_GlcNHglycan | 401 | 405 | PF01048 | 0.748 |
MOD_GlcNHglycan | 442 | 445 | PF01048 | 0.709 |
MOD_GlcNHglycan | 483 | 486 | PF01048 | 0.673 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.558 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.411 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.672 |
MOD_GSK3_1 | 359 | 366 | PF00069 | 0.652 |
MOD_GSK3_1 | 408 | 415 | PF00069 | 0.701 |
MOD_GSK3_1 | 438 | 445 | PF00069 | 0.726 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.490 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.558 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.490 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.476 |
MOD_NEK2_1 | 321 | 326 | PF00069 | 0.741 |
MOD_NEK2_1 | 400 | 405 | PF00069 | 0.682 |
MOD_NEK2_1 | 410 | 415 | PF00069 | 0.748 |
MOD_NEK2_1 | 481 | 486 | PF00069 | 0.550 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.524 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.484 |
MOD_PIKK_1 | 25 | 31 | PF00454 | 0.428 |
MOD_PIKK_1 | 410 | 416 | PF00454 | 0.657 |
MOD_PIKK_1 | 69 | 75 | PF00454 | 0.452 |
MOD_PK_1 | 11 | 17 | PF00069 | 0.697 |
MOD_PKA_1 | 11 | 17 | PF00069 | 0.658 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.580 |
MOD_PKA_2 | 267 | 273 | PF00069 | 0.561 |
MOD_PKA_2 | 336 | 342 | PF00069 | 0.534 |
MOD_PKA_2 | 481 | 487 | PF00069 | 0.758 |
MOD_PKB_1 | 230 | 238 | PF00069 | 0.531 |
MOD_PKB_1 | 304 | 312 | PF00069 | 0.371 |
MOD_Plk_1 | 143 | 149 | PF00069 | 0.498 |
MOD_Plk_1 | 196 | 202 | PF00069 | 0.490 |
MOD_Plk_2-3 | 106 | 112 | PF00069 | 0.490 |
MOD_Plk_4 | 11 | 17 | PF00069 | 0.683 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.490 |
MOD_Plk_4 | 212 | 218 | PF00069 | 0.490 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.522 |
MOD_Plk_4 | 321 | 327 | PF00069 | 0.666 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.516 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.490 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.508 |
MOD_ProDKin_1 | 252 | 258 | PF00069 | 0.438 |
MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.414 |
MOD_ProDKin_1 | 32 | 38 | PF00069 | 0.539 |
MOD_ProDKin_1 | 383 | 389 | PF00069 | 0.647 |
MOD_SUMO_rev_2 | 386 | 394 | PF00179 | 0.750 |
MOD_SUMO_rev_2 | 54 | 64 | PF00179 | 0.459 |
TRG_DiLeu_BaEn_1 | 183 | 188 | PF01217 | 0.490 |
TRG_DiLeu_BaEn_2 | 155 | 161 | PF01217 | 0.563 |
TRG_DiLeu_BaLyEn_6 | 117 | 122 | PF01217 | 0.561 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.561 |
TRG_ENDOCYTIC_2 | 275 | 278 | PF00928 | 0.412 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.562 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.380 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.597 |
TRG_ER_diArg_1 | 230 | 232 | PF00400 | 0.490 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.537 |
TRG_NLS_MonoExtN_4 | 460 | 465 | PF00514 | 0.578 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P667 | Leptomonas seymouri | 72% | 100% |
A0A3R7N9L3 | Trypanosoma rangeli | 54% | 100% |
A0A3S7WZ67 | Leishmania donovani | 80% | 98% |
A4I1I8 | Leishmania infantum | 80% | 98% |
C9ZJX8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AXM3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 98% |
Q4Q9U9 | Leishmania major | 79% | 100% |
V5B841 | Trypanosoma cruzi | 54% | 100% |